Module 3 - Strategic case studies in practice
Name
Updated on Route of
Threshold Information for the Package Leaflet
Comments
Administration
Ethanol
22/11/2019
Oral Parenteral Inhalation
75 mg/kg per dose
See comments above.
This medicine contains x mg of alcohol (ethanol) in each
If you have epilepsy or liver problems, talk to your doctor or pharmacist before taking this medicine.
The amount of alcohol in this medicine may alter the effects of other medicines. Talk to your doctor or pharmacist if you are taking other medicines.
If you are pregnant or breast-feeding, talk to your doctor or pharmacist before taking this medicine.
If you are addicted to alcohol, talk to your doctor or pharmacist before taking this medicine.
Ethanol
22/11/2019
Cutaneous
Zero
This medicine contains x mg alcohol (ethanol) in each
In neonates (pre-term and term newborn infants), high concentrations of ethanol may cause severe local reactions and systemic toxicity due to significant absorption through immature skin (especially under occlusion). The corresponding warning in the SmPC/PL should be added if appropriate. Depending on the product and concentration of ethanol, the warning “flammable” may be necessary. Inclusion of warnings on use near an open flame, lit cigarette or some devices (e.g. hairdryers) should be considered.
It may cause burning sensation on damaged skin.
Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668) EMA/CHMP/302620/2017/EN Rev. 1
Page 8 of 19
Made with FlippingBook Learn more on our blog